HLA-DM Antibody, anti-human, FITC, REAfinity™ 130-124-271 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
HLA-DM Antibody, anti-human, FITC, REAfinity™

The HLA-DM Antibody, anti-human, FITC, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to HLA-DMB. This antibody recognizes Human antigen. The HLA-DM Antibody, anti-human, FITC, REAfinity™ has been validated for the following applications: Staining, Fluorescence, Microscopy, Flow Cytometry, Immunofluorescence, and Immunohistochemistry.

Product Specs
ItemHLA-DM Antibody, anti-human, FITC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-124-271
Quantity30 tests in 60 µL
ApplicationsIntracellular flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
Concentration1:50
Conjugate/TagFITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
TargetHLA-DM
IsotypeIgG1
CloneREA406
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Namemajor histocompatibility complex, class II, DM beta, major histocompatibility complex, class II, DM alpha
NCBI Gene AliasesDMA, RING7, RING6, D6S222E, D6S221E, HLADM
Clonalitymonoclonal
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Mechanisms of peptide repertoire selection by HLA-DMTrends in immunologyOctober 1, 2013Pos W, Sethi DK, Wucherpfennig KW.

(2) HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DMThe Journal of biological chemistryDecember 24, 2010van Lith M, McEwen-Smith RM, Benham AM.

(3) Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patientsInternational immunologyNovember 1, 2006Oldford SA, Robb JD, Codner D, Gadag V, Watson PH, Drover S.

Be the First to Write a Review!